Rebel Curd is a speaker at Global Transfer Pricing: Key Strategies and New Opportunities for Pharma/Biotech Companies. Rebel moderated a panel entitled, “Global Audit Planning and Defense”.
For more information on this event, click here.
Dr. Gene Tien joins CRA's Transfer Pricing Practice
CRA is pleased to announce that Dr. Gene Tien has joined the company as a vice president in the Transfer Pricing Practice.